1 domain / 2 areas / 1 specialization
Berenberg
Data updated
Berenberg, legally Berenberg, Gossler & Co., is a long-established private bank and financial services group founded in 1590 in Hamburg. It operates across investment banking, asset management, corporate banking, and wealth management, and describes itself as one of Europe’s leading private banks.
In the psychedelic ecosystem, Berenberg matters mainly as a public-markets and healthcare-capital-markets participant rather than a dedicated psychedelic specialist. Its published equity and healthcare strategies focus on growth-oriented companies, and its investment banking business has supported multiple life sciences and biotech financings, including healthcare-sector equity transactions.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Berenberg is an internationally active private bank with a strong public-markets orientation through equity research, asset management, and investment banking. Its asset management platform emphasizes quality-growth and structural-growth investing, while its healthcare funds target global healthcare companies across pharma, medtech, life science, and healthcare services. That makes Berenberg relevant to the psychedelic space primarily as a potential public-market and healthcare-sector capital markets participant, though there is no public evidence of a dedicated psychedelic investing focus.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- HQ
- Hamburg; registered office: Hamburg, Germany, Germany
- Website
- Visit